Keyphrases
Estrogen Receptor
100%
Estrogen
100%
Prostate Gland
100%
Prostate
33%
Diethylstilbestrol
33%
Estrogenization
33%
Aging
25%
Rodents
16%
Androgen Receptor
16%
Basal Cell
16%
Secretory Proteins
8%
Older Adults
8%
High Dose
8%
Epithelial Cells
8%
Cell Surface Receptor
8%
Glands
8%
Immunocytochemistry
8%
Stromal Cells
8%
Wild Mice
8%
Cell Lining
8%
Estrogen Receptor Status
8%
Hyperplasia
8%
Prostate Epithelium
8%
Reproductive Tract
8%
No Response
8%
Oil Control
8%
Dorsolateral
8%
Cytokeratin 18
8%
Luminal Cell
8%
Neonatal Exposure
8%
Homozygous mutant
8%
Ventral Prostate
8%
Receptor Downregulation
8%
Inflammatory Cell Infiltrate
8%
Cytokeratin 14
8%
Dorsolateral Prostate
8%
Severe Dysplasia
8%
Penile Intraepithelial Neoplasia (PeIN)
8%
Prostatic Stromal Cells
8%
Prostatic Lesions
8%
Epithelial Dysplasia
8%
Medicine and Dentistry
Receptor Study
100%
Estrogen Receptor
100%
Diethylstilbestrol
30%
Stromal Cell
15%
Androgen Receptor
15%
Basal Cell
15%
Epithelial Cell
7%
Receptor Expression
7%
Immunocytochemistry
7%
Upregulation
7%
Hyperplasia
7%
Inflammatory Cell
7%
Drug Megadose
7%
Dysplasia
7%
Cell Receptor
7%
Secretory Protein
7%
Cellular Infiltration
7%
Keratin 14
7%
Receptor down Regulation
7%
Prostate Lobe
7%
Prostate Epithelium
7%
Prostatic Intraepithelial Neoplasia
7%
Keratin 18
7%
Epithelial Dysplasia
7%
Veterinary Science and Veterinary Medicine
Mouse
100%
Prostate
100%
Estrogen Receptor
100%
Diethylstilbestrol
30%
Dysplasia
15%
Stromal Cell
15%
Androgen Receptor
15%
Neuroscience
Prostate
100%
Estrogen Receptor
100%
Diethylstilbestrol
30%
Androgen Receptor
15%
Dysplasia
15%
Receptor Expression
7%
Immunocytochemistry
7%
Epithelial Cells
7%
Secretory Protein
7%
Receptor down Regulation
7%
Hyperplasia
7%
Cell Receptor
7%
Cytokeratin 14
7%
Cytokeratin 18
7%
Pharmacology, Toxicology and Pharmaceutical Science
Mouse
100%
Estrogen Receptor
100%
Diethylstilbestrol
30%
Androgen Receptor
15%
Dysplasia
15%
Wild Type Mouse
7%
Hyperplasia
7%
Cell Receptor
7%
Secretory Protein
7%
Cytokeratin 18
7%
Cytokeratin 14
7%
Prostatic Intraepithelial Neoplasia
7%